首页> 外文会议>World congress on medical physics and biomedical engineering;International congress of the IUPESM >The use of aSi EPID for in vivo dosimetry in photon beams: clinical experience
【24h】

The use of aSi EPID for in vivo dosimetry in photon beams: clinical experience

机译:aSi EPID在光子束体内剂量测定中的使用:临床经验

获取原文

摘要

In vivo dose verification is used to prevent major deviations between the prescribed dose and the dose really delivered to the patient. This work presents a quick and simple alternative method for verification of dose delivered to the patient using photon beams. During the treatment session, a transit dose is measured with the EPID and the dose in the patient is estimated from back projection of the portal dose. This method was validated by phantom measurement using an ionisation chamber. Central axis doses estimated by this formalism were compared with measured dose. The feasibility of the method and its applicability in clinical use has been evaluated on patients treated with conformal therapy (18 patients, 325 treatment beams over 8 months) and with IMRT (9 patients, 165 treatment beams). Using this amount of data, the definition of action levels became possible. The uncertainties are within the accepted tolerance of classical in vivo dosimetry (1SD = 3.5% for conformational beams and 1SD = 3.6% for IMRT). The proposed method for in vivo dose verification is very simple to implement and to use in clinics. Measurements can be repeated during several sessions giving the opportunity to built new strategies for the validation by statistical evaluation of the data. The trending of in vivo dose along the treatment becomes also possible.
机译:体内剂量验证用于防止处方剂量和实际输送给患者的剂量之间出现重大差异。这项工作提出了一种快速,简单的替代方法,用于验证使用光子束传递给患者的剂量。在治疗期间,用EPID测量转运剂量,并根据门禁剂量的背投估算患者体内的剂量。使用电离室通过幻像测量验证了该方法。将这种形式主义估计的中心轴剂量与测得的剂量进行比较。该方法的可行性及其在临床中的适用性已在接受保形治疗的患者(18例,8个月内接受325个治疗束)和接受IMRT治疗的患者(9例,接受165个治疗束)中进行了评估。使用这些数据量,可以定义操作级别。不确定性在经典体内剂量学的可接受公差范围内(对于构象光束,1SD = 3.5%;对于IMRT,1SD = 3.6%)。所提出的体内剂量验证方法非常易于实施和在临床中使用。可以在多个会话中重复进行测量,从而有机会通过对数据的统计评估来建立新的验证策略。沿着治疗的体内剂量趋势也变得可能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号